RPH.RO Ropharma Bras

Healthcare Pharmaceutical Retailers Bucharest Stock Exchange
0.2560 RON
Close of Oct 29, 2026
0.1580 0.2800
Market cap
RON 131M
P/E
-
P/B
0.49x
ROE
-0.7%
Dividend yield
3.23%
Fundamental score
1.8/5

Ratios use the latest price and the fiscal year ending Jun 2025.

Is RPH.RO undervalued?

Graham number

The Graham number of Ropharma Bras cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ropharma Bras fundamental analysis

7 of 21 checks passed

ROE 0/2

Low return on equity (-0.7%), below 10%.

ROA 0/1

Return on assets (-0.2%) is below the industry median (-0.2%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-122.4%) is below the industry median (-33.3%).

Revenue Growth 2/2

Revenue grew 15.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (9.2%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Cash Runway 2/2

Loss-making but free cash flow is positive.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (0.5x) is below the industry median (1.1x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (3.2%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Ropharma Bras stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ropharma Bras

S.C. Ropharma S.A., together with its subsidiaries, operates a chain of pharmacies in Romania. The company offers medicines on prescription, over-the-counter (OTC) medications, food supplements, dermato-cosmetics, cosmetics, and medical devices, as well as other healthcare products dispensed through pharmacies. It also provides medical services in various areas, including oncology, hematology, oncological surgery and HIPEC, bariatric surgery, thoracic surgery, and robotic su…

Full company profile